1/28/20 16:05 | 1/26/20 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | M.d | 0 | 0.00 | 0 | 13 | 13 | 105 | D | | | | | | | | | | | | | | |
1/29/19 18:51 | 1/26/19 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO | M.d | 0 | 0.00 | 0 | 8 | 9 | 93 | D | | | | | | | | | | | | | | |
12/19/18 16:11 | 12/17/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S.d | -91 | 6.39 | 0 | -14 | -14 | 85 | D | | | | | | | | | | | | | | |
12/19/18 16:11 | 12/19/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | M.d | 0 | 0.00 | 0 | 10 | 13 | 85 | D | | | | | | | | | | | | | | |
11/19/18 16:27 | 11/15/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | See Rema | S | -118 | 8.26 | 0 | -14 | -14 | 90 | D | | | | | | | | | | | | | | |
10/16/18 16:16 | 10/15/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | See Rema | S | -85 | 5.94 | 0 | -14 | -12 | 104 | D | | | | | | | | | | | | | | |
9/19/18 21:22 | 5/15/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | See Rema | S.m | -327 | 7.64 | 0 | -43 | -27 | 118 | D | | | | | | | | | | | | | | |
7/18/18 16:58 | 7/15/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S | -116 | 8.10 | 0 | -14 | -8 | 161 | D | | | | | | | | | | | | | | |
6/19/18 17:03 | 6/19/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | M.d | 0 | 0.00 | 0 | 5 | 3 | 175 | D | | | | | | | | | | | | | | |
6/18/18 16:43 | 6/15/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S | -122 | 8.57 | 0 | -14 | -8 | 170 | D | | | | | | | | | | | | | | |
4/26/18 16:55 | 4/25/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S | -108 | 7.58 | 0 | -14 | -7 | 184 | D | | | | | | | | | | | | | | |
1/30/18 21:01 | 1/26/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | See Rema | M.d | 0 | 0.00 | 0 | 5 | 3 | 199 | D | | | | | | | | | | | | | | |
1/30/18 21:01 | 1/26/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | See Rema | S.d | -19 | 11.02 | 0 | -2 | -1 | 199 | D | | | | | | | | | | | | | | |
1/30/18 20:54 | 12/19/17 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | See Rema | M.a | 0 | 0.00 | 0 | 5 | 3 | 196 | D | | | | | | | | | | | | | | |
1/30/18 20:54 | 12/19/17 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | See Rema | S.a | -16 | 10.14 | 0 | -2 | -1 | 196 | D | | | | | | | | | | | | | | |
12/20/17 16:56 | 12/19/17 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | M.d | 0 | 0.00 | 0 | 5 | 9 | 59 | D | | | | | | | | | | | | | | |
12/20/17 16:56 | 12/19/17 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S.d | -16 | 10.14 | 0 | -2 | -3 | 59 | D | | | | | | | | | | | | | | |
8/31/16 20:47 | 4/25/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S.a | -595 | 31.94 | 10 | -19 | -25 | 56 | D | | -74 | -60 | -65 | -68 | 17 | -2 | 1 | -3 | 2 | 20 | -2 | -7 | |
8/30/16 19:23 | 8/29/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S | -102 | 10.87 | 11 | -9 | -5 | 192 | D | | -73 | -54 | -64 | -67 | 15 | -8 | 0 | -3 | -1 | 22 | -3 | -8 | |
7/29/16 16:50 | 7/27/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S | -324 | 35.00 | 9 | -9 | -4 | 202 | D | | -5 | 46 | 21 | 21 | 19 | 9 | 5 | -48 | -26 | -22 | -19 | -24 | |
7/26/16 17:54 | 7/22/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | M.d | 90 | 0.4800 | 9 | 188 | 806 | 211 | D | | -11 | 38 | 4 | -1 | 17 | 6 | 1 | 1 | -74 | -69 | -66 | -74 | |
7/26/16 17:54 | 7/25/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S.d | -321 | 34.18 | 9 | -9 | -4 | 211 | D | | -11 | 38 | 4 | -1 | 17 | 6 | 1 | 1 | -74 | -69 | -66 | -74 | |
6/29/16 19:21 | 6/27/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S | -256 | 27.23 | 11 | -9 | -22 | 33 | D | | -23 | -16 | 17 | 16 | -14 | 0 | -3 | -3 | 1 | 20 | -56 | -68 | |
6/2/16 21:34 | 5/31/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S | -421 | 30.05 | 7 | -14 | -25 | 42 | D | | | -14 | 16 | 1 | 22 | 7 | 6 | -7 | 7 | -10 | -69 | -71 | |
4/27/16 16:44 | 4/25/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S | -595 | 31.94 | 8 | -19 | -25 | 56 | D | | | 8 | 26 | 27 | 4 | 4 | 0 | -2 | -7 | -3 | 16 | -57 | |
3/29/16 19:09 | 3/28/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aunins John G. | MA | O | CTO,EVP | S | -224 | 23.89 | 6 | -9 | -11 | 75 | D | | | -38 | -32 | -6 | -17 | -1 | -2 | -2 | 11 | 23 | 11 | -50 | -58 |